GLAXOSMITHKLINE S.A.E Glaxo Smith Kline (BIOC.CA) - Listing Committee Decision
10/03/2022
10/03/2022
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Listing Committee held on 09/03/2022 decided to address the company to abide by the provision of Article 31 of the Listing Rules and Article 45 of the Executive Regulations.
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Listing Committee held on 09/03/2022 decided to address the company to abide by the provision of Article 31 of the Listing Rules and Article 45 of the Executive Regulations.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GlaxoSmithKline SAE published this content on 10 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 March 2022 13:23:28 UTC.
